Growth Capitalist (https://growthcapitalist.com/tag/biomed/page/2/)
Janney Montgomery Scott hired Debjit Chattopadhyay as a research analyst to cover the biotech sector, continuing the investment bank's expansion of its healthcare research team.
Three months after Telesta Therapeutics (TST.TO) raised $28.6 million in a private placement of stock, the company’s shares lost almost 40% of their value when a Food and Drug Administration advisory panel expressed a negative view of a drug Telesta is developing.
F-Star, a clinical-stage developer of antibodies to treat cancer, named former GlaxoSmithKline (GSK) executive Neil Brewis as its chief scientific officer.
MYOS Corporation (NASDAQ CM:MYOS) announced that it has raised $1,816,515 in a Registered Direct transaction.
